Al Harrington had seen this day coming for years.
As the former NBA forward was in Las Vegas and strolling through MJBizCon, the largest convention for the cannabis trade in the United States, a friend texted him an Instagram post with the news that Major League Baseball will no longer test for marijuana in the minor leagues, a response to opioid use among professional athletes. It was a pivotal turning point for advocates, such as Harrington, who believe cannabis is a healthier medicinal option.
Harrington, the founder of a cannabis company, Viola, has been at the forefront of championing a similar message in basketball.
“I think the day-to-day pain management issues that players deal with can be dealt with through cannabis,” Harrington said of athletes who are often prescribed pain relievers following surgery, including highly addictive opioids. “Something that is all natural and nowhere near as harmful as the stuff that they’re using now.”
Medical marijuana has been legalized in 33 states, and 11 states have voted to allow it for recreational use. Although he’s pro-marijuana, Harrington believes cannabidiol (CBD), the less-stigmatized and less-psychoactive cousin of weed, is an easier product for the NBA to accept.
Along with co-founders Joe Abunassar, a well-known NBA trainer, and Sanford Kunkel, a former team physician of the Indiana Pacers, Harrington started a hemp-derived CBD brand, Harrington Wellness. [Read More @ The Washington Post]
Your email address will not be published. Required fields are marked *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Comment *
Notify me of follow-up comments by email.
Notify me of new posts by email.
Δ
A bill to increase the amount of marijuana a person can possess before facing stiff criminal penalties failed 15-9 in the Hawaii Senate on Monday. It was the second defeat…
By Hannah King and Arin Aragona Plans for Kentucky’s medical cannabis program took a significant turn last week with the passage of House Bill 829 and the implementation of emergency…
By Steven Ascher and Anna M.Windemuth The unique status of the cannabis business — legal in a majority of states, but still illegal under federal law — creates a thorny…
By Courtney A. Hunter and Jessalyn H. Zeigler Demand for cannabidiol (CBD) products continues to climb, and the market has risen to the occasion. There is now a robust array…